Premium
Biochemical analysis of meconium in fetuses presumed to have cystic fibrosis
Author(s) -
Brock David J. H.,
Barron Lilias
Publication year - 1986
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.1970060409
Subject(s) - meconium , cystic fibrosis , fetus , albumin , endocrinology , medicine , pancreas , biology , andrology , pregnancy , genetics
A series of proteins (albumin, transferrin, a 1 ‐ antitrypsin, alpha‐fetoprotein and pancreatic oncofetal antigen) and enzymes (γ‐glutamyltranspeptidase, aminopeptidase M, alkaline phosphatase, a‐glucosidase and protease) was measured in fetal meconium extracts. There were 19 fetuses thought to have cystic fibrosis (CF), 13 with neural tube defects, three with chromosome abnormalities and 19 normal controls, all with gestational ages between 18 and 21 weeks. With the exception of alpha‐fetoprotein, all the proteins and enzymes were significantly elevated in the CF meconium extracts. The most definitive indicator of a CF fetus was the albumin concentration, where the mean level was five times that found in the control groups. However, five of 19 fetuses assumed to have CF had albumin in the normal range. In these cases the meconium protease levels were grossly elevated. Furthermore, in the same five fetuses meconium concentration of pancreatic oncofetal antigen, a protein synthesized in the fetal pancreas, was also greatly raised. We suggest that post‐mortem examination of a fetus thought to have CF should include measurement of meconium albumin, protease and pancreatic oncofetal antigen.